Institutional investors purchased a net $956.00 shares of ROSG during the quarter ended December 2014 and now own 3.71% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Sold 5.0 Thousand shares of Rosetta Genomics Ltd